Medication info
Rina Empa Tablet 25/5mg (Empagliflozin, Linagliptin)

Rina Empa Tablet 25/5mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Linagliptin Micronized›5mg / 1 tabletEmpagliflozin›25mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Green Cross
Appearance
Pale pink round film-coated tablet
Packaging
PTP - 30 tablets/box [(10 tablets/PTP x 3)], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202402281 · Approved 2024.09.23

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is well tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose of this medicine is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and resume the usual dosing schedule. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment based on age is necessary. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
(Co., Ltd.) Green Cross

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes by combining Empagliflozin and Linagliptin. It is an adjunct to diet and exercise to help manage blood sugar more effectively. This can improve blood sugar levels and assist in diabetes treatment.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is well tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose of this medicine is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and resume the usual dosing schedule. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment based on age is necessary. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains two ingredients, Empagliflozin and Linagliptin, for the treatment of diabetes. It is important not to use this medication in certain patients. For example, it should not be administered to individuals with allergies to its ingredients, patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Patients with impaired kidney function may experience reduced effectiveness from this medication, thus regular kidney function tests are recommended before and during treatment. In patients with mild to moderate heart failure, caution is advised, and it is not recommended for patients with severe heart failure. During treatment with this medication, rare skin conditions such as acute pancreatitis or blistering similar to bullous pemphigoid may occur; if such symptoms appear, discontinue use immediately and consult a physician. The most common side effect is urinary tract infection, with rare occurrences of hypoglycemia, pancreatitis, and allergic reactions. This medication may increase the risk of hypoglycemia, especially when taken with other medications that lower blood sugar, such as insulin or sulfonylureas. Additionally, in patients who are dehydrated or have low blood pressure, particularly seniors aged over 75, there is a risk of dehydration or hypotension, thus it should be used cautiously. This medication can rarely cause serious infections like Fournier’s gangrene in diabetes patients; if pain, swelling, or fever around the genital area occurs, immediate medical attention is necessary. Women who are pregnant or breastfeeding should avoid using this medication, particularly during breastfeeding as it may transfer to the infant through breast milk, and discontinuing breastfeeding is recommended. This medication is not indicated for children under 18 years of age as safety and efficacy have not been established. In the case of overdose, treatment to remove the unabsorbed medication from the gastrointestinal tract is required, and there are no specific antidotes; immediate medical care is necessary. Finally, it is important to keep this medication out of reach of children and store it in its original container to maintain quality.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infection
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 157 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • pruritus
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • urinary retention
  • interstitial nephritis
  • amylase increase
  • lipase increase
  • increased hematocrit
  • increased serum lipids
  • elevated blood creatinine
  • nasopharyngitis
  • Fournier's gangrene
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorders
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • stomach cancer
  • colorectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • hearing loss
  • dizziness
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stone disease
  • cervical inflammation
  • headache
  • intracranial aneurysm
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stone disease
  • hematuria
  • renal mass
  • urinary retention
  • vulvar pruritus
  • genital pruritus
  • hypoglycemia
  • obesity
  • hyperlipidemia
  • hyponatremia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • age-related dyspnea
  • productive cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • contusion
  • palpitations
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular disease
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorder
  • acute cholecystitis
  • autoimmune hepatitis
  • gallstone disease
  • hepatitis
  • otalgia
  • position-related vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • chest discomfort
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

PTP - 30 tablets/box [(10 tablets/PTP x 3)], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.